Toward Systems Pathology for PTEN Diagnostics

2019 ◽  
Vol 10 (5) ◽  
pp. a037127 ◽  
Author(s):  
Nahal Haddadi ◽  
Glena Travis ◽  
Najah T. Nassif ◽  
Ann M. Simpson ◽  
Deborah J. Marsh
Keyword(s):  
2010 ◽  
Vol 49 (02) ◽  
pp. 173-185 ◽  
Author(s):  
H. Tanaka

Summary Objectives: Recent important advances in the human genomics and post-genomic “omics” are now bringing about a new medical care which we call “omics-based medicine”. In this article, we investigated the development and future possibilities of omics-based medicine. Methods: We divided the development of omics-based medicine into three generations in order to clarify the main clinical goals and characteristics of informatics method of each generation, together with its future possibilities. Results: The first generation of omics-based medicine started with “genomic medicine” based on the inborn individual differences of genome. It has opened the study of genetic polymorphism of the diseases and promoted the personalized medication based on the pharmacogenetic/pharmacogenomic difference of the drug response. In the second generation of omics-based medicine, owing to the advances in the high-throughput technology, vast amount of the various post-genomic disease omics data containing comprehensive molecular information of diseased somatic cells has become available. It reflects the ongoing state of diseases more closely and enables the predictive medicine such as prognosis prediction of disease by applying the data-driven analysis. Finally, due to the rapidly growing knowledge about the cellular molecular network, system-level understanding of the disease, called systems pathology, becomes possible. It can fully exploit the substantial contents of disease omics and will lead to a comprehensive understanding of disease process by using model-driven analysis. Conclusion: Omics-based medicine and systems pathology will realize a new personalized and predictive medicine.


2017 ◽  
Vol 13 (7S_Part_26) ◽  
pp. P1281-P1281
Author(s):  
Jennifer L. Rollo ◽  
John W. Crawford ◽  
Xiaoxian Zhang ◽  
John Hardy

2019 ◽  
Vol 156 (6) ◽  
pp. S-222
Author(s):  
Jon M. Davison ◽  
John R. Goldblum ◽  
Udhayvir Grewal ◽  
Kevin McGrath ◽  
Christopher Deitrick ◽  
...  

2009 ◽  
Vol 455 (2) ◽  
pp. 193-196 ◽  
Author(s):  
Niels Grabe ◽  
Peter Schirmacher

2009 ◽  
Vol 45 (8) ◽  
pp. 1518-1526 ◽  
Author(s):  
Michael J. Donovan ◽  
Angeliki Kotsianti ◽  
Valentina Bayer-Zubek ◽  
David Verbel ◽  
Mikhail Teverovskiy ◽  
...  

2008 ◽  
Vol 453 (4) ◽  
pp. 309-312 ◽  
Author(s):  
Manfred Dietel ◽  
Reinhold Schäfer

2012 ◽  
pp. 197-207 ◽  
Author(s):  
José Costa ◽  
Michael J. Donovan
Keyword(s):  

2021 ◽  
Vol 8 ◽  
Author(s):  
Felix Tretter ◽  
Olaf Wolkenhauer ◽  
Michael Meyer-Hermann ◽  
Johannes W. Dietrich ◽  
Sara Green ◽  
...  

Precision medicine and molecular systems medicine (MSM) are highly utilized and successful approaches to improve understanding, diagnosis, and treatment of many diseases from bench-to-bedside. Especially in the COVID-19 pandemic, molecular techniques and biotechnological innovation have proven to be of utmost importance for rapid developments in disease diagnostics and treatment, including DNA and RNA sequencing technology, treatment with drugs and natural products and vaccine development. The COVID-19 crisis, however, has also demonstrated the need for systemic thinking and transdisciplinarity and the limits of MSM: the neglect of the bio-psycho-social systemic nature of humans and their context as the object of individual therapeutic and population-oriented interventions. COVID-19 illustrates how a medical problem requires a transdisciplinary approach in epidemiology, pathology, internal medicine, public health, environmental medicine, and socio-economic modeling. Regarding the need for conceptual integration of these different kinds of knowledge we suggest the application of general system theory (GST). This approach endorses an organism-centered view on health and disease, which according to Ludwig von Bertalanffy who was the founder of GST, we call Organismal Systems Medicine (OSM). We argue that systems science offers wider applications in the field of pathology and can contribute to an integrative systems medicine by (i) integration of evidence across functional and structural differentially scaled subsystems, (ii) conceptualization of complex multilevel systems, and (iii) suggesting mechanisms and non-linear relationships underlying the observed phenomena. We underline these points with a proposal on multi-level systems pathology including neurophysiology, endocrinology, immune system, genetics, and general metabolism. An integration of these areas is necessary to understand excess mortality rates and polypharmacological treatments. In the pandemic era this multi-level systems pathology is most important to assess potential vaccines, their effectiveness, short-, and long-time adverse effects. We further argue that these conceptual frameworks are not only valid in the COVID-19 era but also important to be integrated in a medicinal curriculum.


Sign in / Sign up

Export Citation Format

Share Document